SCHEMBL26513756

SCHEMBL26513756

C/N=C1/NN=C(N)/C1=N/Nc1cccc(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DEPTOR Q8TB45 1/20 0.49
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
NOS1 P29475 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EGFR P00533 3/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
ABL1 P00519 1/20 0.33
ABL2 P42684 1/20 0.33
IDO1 P14902 2/20 0.32
BRAF P15056 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26512340 0.82 DEPTOR (0.51) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7616338 0.82 DEPTOR (0.51) DEPTORMEN1KMT2ASMN1; SMN2MAPK1
SCHEMBL26512521 0.82 DEPTOR (0.51) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7616331 0.82 DEPTOR (0.51) DEPTORMEN1KMT2ASMN1; SMN2MAPK1
SCHEMBL26513097 0.78
SCHEMBL922086 0.76 DEPTOR (0.61) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL6637470 0.76 DEPTOR (0.54) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL922049 0.70 DEPTOR (0.50) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL924498 0.70 DEPTOR (0.50) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL922050 0.70 DEPTOR (0.50) DEPTORMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES GMPS, PDE11A, CGAS DEPTOR 1931/4885MEN1 4255/4885KMT2A 4134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.